With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

The S&P 500 Index ( $SPX) ( SPY) today is down -0.41%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is down -0.43%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is down -0.35%. June E-mini S&P futures ...

AbbVie ABBV stock has gained 16.1% so far this year compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

AbbVie’s stock is climbing like your caffeine intake before a deadline, gaining traction despite a 0.60% dip over the past ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The general mood among these heavyweight investors is divided, with 43% leaning bullish and 21% bearish. Among these notable ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...